Cost utility of prenatal diagnosis and the risk-based threshold
- 1 January 2004
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 363 (9405), 276-282
- https://doi.org/10.1016/s0140-6736(03)15385-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Decision Analysis of Prenatal Testing for Chromosomal Disorders: What Do the Preferences of Pregnant Women Tell Us?Genetic Testing, 2001
- Procedure-related miscarriages and down syndrome–affected births: implications for prenatal testing based on women's preferencesObstetrics & Gynecology, 2000
- Preferences of women facing a prenatal diagnostic choice: long-term outcomes matter mostPrenatal Diagnosis, 1999
- ECONOMIC EVALUATION OF PRENATAL DIAGNOSIS: A METHODOLOGICAL REVIEWPrenatal Diagnosis, 1996
- Current Maternal Age Recommendations for Prenatal Diagnosis: A Reappraisal Using the Expected Utility TheoryFetal Diagnosis and Therapy, 1995
- Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for ScreeningNew England Journal of Medicine, 1994
- Risk evaluation of CVSPrenatal Diagnosis, 1993
- Pregnancy Termination Because of Chromosomal Abnormalities: A Study of 26 950 Amniocenteses in the SoutheastSouthern Medical Journal, 1991
- The Safety and Efficacy of Chorionic Villus Sampling for Early Prenatal Diagnosis of Cytogenetic AbnormalitiesNew England Journal of Medicine, 1989
- RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMENThe Lancet, 1986